Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901, Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0440-05
Published April 16, 2014 · Recall initiated: March 3, 2014
Summary
FDA records drug Class III recall D-1227-2014, published April 16, 2014 and initiated March 3, 2014. Recalling firm: Novartis Pharmaceuticals Corp.; Status: Terminated; Reported quantity: 10,930 Bottles; Lot: Lot #: F0126. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t
What to do
Voluntary: Firm initiated · Letter
Get an email if RITALIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- RITALIN
- Manufacturer
- Novartis Pharmaceuticals Corp.
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0300780441056
- Lot
- Lot #: F0126
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARitalin HCl (methylphenidate HCl) USP, 20 mg, 100 tablets per Bottle, Rx only, Mfd. by: NovartisApril 16, 2014
- FDADemerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01,April 16, 2014
- FDAetomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single Dose Vials (NDCApril 16, 2014
- FDARanitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: Shasun Pharmaceuticals Limited,April 16, 2014
- FDABlack Ant, 4600 mg x 4. Product is packaged in a small green box with gold lettering on the front, the backApril 16, 2014
- FDASpiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use WithApril 16, 2014
Questions about this recall
Was Ritalin HCl (methylphenidate HCl) USP, 10 mg, 100 tablets per Bottle, Rx only, Mfd. by: Novartis Pharmaceuticals Corp. Suffern, NY 10901, Dist. by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC 0078-0440-05 recalled?
Yes. FDA published recall D-1227-2014 on April 16, 2014. Reported hazard: Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets. Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert. The individual Medication Guides are attached to the Package Insert via a perforation. Although t
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: RITALIN. UPC: 0300780441056.